Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Sublingual Misoprostol and Routine Third Stage Prophylaxis for the Prevention of Postpartum Haemorrhage: A Randomised Controlled Clinical Trial.

NCT04044287 is registered in ClinicalTrials.gov with The University of The West Indies as lead sponsor.

NCT NCT04044287
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04044287 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Sublingual Misoprostol and Routine Third Stage Prophylaxis for the Prevention of Postpartum Haemorrhage: A Randomised Controlled Clinical Trial.
Lead sponsor
The University of The West Indies
Phase
Phase 3
Overall status
Unknown status
Start date
January 1, 2013
Completion date
December 31, 2019
Enrollment
1,496 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

postpartum hemorrhage